Overview

Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients

Status:
Completed

Trial end date:
2015-04-01

Target enrollment:

Participant gender:

Summary

Efficacy and Safety of My-Rept® Tablet(Mycophenolate Mofetil 500mg/Tab.) versus My-Rept® Capsule(Mycophenolate Mofetil 250mg/Cap.) in Combination with Tacrolimus in Kidney Transplant Patients

Phase:

Phase 4

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus